like our patient in the literature. One possible explanation could be proposed for this association. After receiving treatment of the primary lesion, the condition of patient with or without immunodeficiency is more likely to be vulnerable to secondary malignancy. In conclusion, we emphasize that when patients diagnosed with cutaneous lymphoma present new skin lesions, clinicians should consider skin biopsies and further immunostaining.
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Dear Editor: Mycosis fungoides (MF) represents the most common type of cutaneous T-cell lymphoma, characterized by epidermotropic proliferation of small-to medium-sized T-cells 1 . On the other hand, primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is composed of a clonal proliferation of mature, activated gamma-delta T-cells with a cytotoxic phenotype 1 . Here, we report a case of MF following PCGD-TCL. To our knowledge, this is the first reported case.
A 52-year-old woman presented with a 2-year history of erythematous lesion with crust and erosion on the right pubic area. She had no particular medical history. A biopsy specimen revealed infiltration of medium to large sized atypical lymphoid cells in the dermis and subcutis (Fig. 1) . We received the patient's consent form about publishing all photographic materials. The majority of atypical cells were CD3+, CD4−, CD8−, and CD56+. Also immunostaining revealed the absence of T-cell receptor (TCR)-βF1. Laboratory examination revealed leukocytosis (9,900/μl; normal: 3,150∼8,630/μl). Positron emission tomography showed no internal organ involvement. The patient was diagnosed with PCGD-TCL. The patient received multidrug chemotherapy; 6 cycles of bortezomib, cyclophosphamide, adriamycin, vincristine, and prednisolone. After 1 year PCGD-TCL recurred and the patient received radiotherapy after 6 cycles of chemotherapy. This resulted in complete response for PCGD-TCL. Three years later, the patient revisited with erythematous scaly patches on her extremities and trunk. A biopsy specimen showed epidermal and dermal infiltration of atypical lymphocyte (Fig. 2) . Phenotypes of these cells were CD3+, CD4+, MF is a risk factor for development of other hematological disorders such as lymphomatoid papulosis, CD30+ anaplastic large cell lymphoma and B-cell lymphoma [3] [4] [5] . In addition, several cases were reported that molecular analyses revealed that the same neoplastic clone of T lymphocytes was present in MF and associated lymphoma 3 . In this case, however, different lymphomas with independent findings of immunohistochemistry occurred sequentially, MF occurring after PCGD-TCL. There is no reported case
